ICD-10 Code B60.00 | Babesiosis, unspecified Symptoms, Diagnosis, Billing

Babesiosis, unspecified is a parasitic infection caused by protozoa of the genus Babesia, primarily transmitted through tick bites. This condition can lead to severe illness, particularly in immunocompromised individuals. Accurate coding with ICD-10 Code B60.00 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage cases of this potentially serious infection.

What is ICD-10 Code B60.00 for Babesiosis, unspecified?

ICD-10 Code B60.00 represents Babesiosis, unspecified, a disease caused by the Babesia parasite, which infects red blood cells. This code is used when the specific type of Babesia is not identified. It is crucial for clinical documentation and billing when diagnosing patients with symptoms consistent with babesiosis, allowing for appropriate treatment and management of the condition.

ICD-10 Code B60.00 – Clinical Definition and Explanation of Babesiosis, unspecified

Babesiosis is primarily caused by the bite of infected Ixodes ticks, leading to the invasion of red blood cells by the Babesia parasite. The condition can progress to severe illness, particularly in those with weakened immune systems, necessitating prompt medical attention.

Key Clinical Features:

• Fever and chills, often resembling malaria.
• Fatigue and malaise, which may be profound.
• Hemolytic anemia, leading to jaundice.
• Splenomegaly and hepatomegaly in severe cases.

ICD-10 Code B60.00 for Babesiosis, unspecified – SOAP Notes & Clinical Use

ICD-10 Code B60.00 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans for babesiosis. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and facilitating appropriate billing.

What Does ICD-10 Code B60.00 for Babesiosis, unspecified Mean in SOAP Notes?

In SOAP notes, ICD-10 Code B60.00 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of babesiosis. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code B60.00 – Babesiosis, unspecified

Babesiosis requires prompt treatment to prevent complications, especially in high-risk populations. Hospitalization may be necessary for severe cases.

Antibiotic Therapy:

• First-line: Atovaquone plus azithromycin for 7-10 days.
• Alternative: Clindamycin plus quinine for 7-10 days.

Supportive Care:

• Hydration and electrolyte management.
• Blood transfusions in cases of severe anemia.
• Monitoring for complications such as respiratory distress.

Infection Control:

• Implement tick-borne disease precautions.
• Educate patients on tick avoidance strategies.
• Report cases to public health authorities during outbreaks.

How to Document Symptoms of Babesiosis, unspecified (ICD-10 B60.00) in SOAP Notes

Subjective:

• Patient reports fever, chills, and fatigue.
• History of recent tick exposure or outdoor activities.
• Complaints of jaundice and dark urine.

Objective:

• Vital signs: Fever 101°F, tachycardia.
• Physical exam: Splenomegaly noted.
• Laboratory findings: Positive Babesia PCR test.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Babesiosis, unspecified (ICD-10 Code B60.00)

Assessment:

• Diagnosis: Babesiosis, unspecified, moderate severity.
• ICD-10 Code: B60.00.
• Contributing factors: Recent tick exposure.

Plan:

• Initiate treatment with atovaquone and azithromycin.
• Educate patient on tick prevention strategies.
• Schedule follow-up in one week to monitor progress.

Treatment & Plan Section for ICD-10 Code B60.00 – Babesiosis, unspecified

• First-line pharmacologic treatment: Atovaquone plus azithromycin.
• Non-pharmacologic strategies: Educate on tick avoidance and personal protective measures.
• Monitoring: Regular follow-up to assess treatment response and manage complications.
• Follow-up practices: Schedule repeat blood tests to monitor for hemolysis.

Using ICD-10 Code B60.00 for Babesiosis, unspecified in Billing & SOAP Note Compliance

• Select appropriate ICD-10 code based on clinical findings and documentation.
• Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
• Ensure treatment plans align with clinical guidelines to support justified billing.
• Include relevant CPT codes for laboratory tests and treatments associated with babesiosis.

Related ICD-10 Codes Often Used with Babesiosis, unspecified

• A92.0 – Dengue fever

ICD-10 Code B60.00 in Medical Billing and Insurance for Babesiosis, unspecified

ICD-10 Code B60.00 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.

Billing Notes:

• Ensure accurate documentation of symptoms and treatment to support the ICD-10 claim.
• Use the code in conjunction with relevant CPT codes for laboratory tests and treatments.
• Document patient history and exposure to ticks to justify the diagnosis.

Common CPT Pairings: